STAGE III NSCLC
Clinical trials for STAGE III NSCLC explained in plain language.
Never miss a new study
Get alerted when new STAGE III NSCLC trials appear
Sign up with your email to follow new studies for STAGE III NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New two-part attack aims to shrink lung tumors before surgeons remove them
Disease control Recruiting nowThis trial is testing a treatment plan for stage III non-small cell lung cancer. It combines chemotherapy and immunotherapy to try to shrink tumors before surgery. The goal is to see if this approach helps more patients have successful, complete tumor removal. After surgery, pati…
Matched conditions: STAGE III NSCLC
Phase: PHASE2 • Sponsor: Fondazione Ricerca Traslazionale • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for frail lung cancer patients: gentler combo therapy trial
Disease control Recruiting nowThis study is testing a two-step treatment for people with stage III non-small cell lung cancer who are elderly or have other health conditions that make standard aggressive treatments too risky. It combines immunotherapy and chemotherapy first, followed by a shorter course of ra…
Matched conditions: STAGE III NSCLC
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Mar 05, 2026 14:03 UTC